Risk of depression in patients with inflammatory bowel disease

被引:30
作者
Geiss, Thomas [1 ]
Schaefert, Rainer M. [2 ,3 ]
Berens, Sabrina [2 ]
Hoffmann, Peter [1 ]
Gauss, Annika [1 ]
机构
[1] Heidelberg Univ, Univ Hosp Heidelberg, Dept Gastroenterol & Hepatol, Heidelberg, Germany
[2] Heidelberg Univ, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany
[3] Univ Hosp Basel, Dept Psychosomat, Basel, Switzerland
关键词
Crohn disease; depression; inflammatory bowel diseases; risk factors; ulcerative colitis; QUALITY-OF-LIFE; FORM HEALTH SURVEY; CROHNS-DISEASE; ULCERATIVE-COLITIS; ANXIETY; INDEX; QUESTIONNAIRE; COMORBIDITY; VALIDITY; IMPACT;
D O I
10.1111/1751-2980.12644
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVED: Depression is more prevalent in patients with inflammatory bowel disease (IBD) than in the general population. This study evaluated disease-related risk factors for depression in Crohn's disease (CD) and ulcerative colitis (UC). METHODS: Altogether 348 patients with IBD (228 with CD, 120 with UC) were included at our Outpatient IBD Clinic. Their characteristics, laboratory results and scores of depression, quality of life and clinical disease activity were retrospectively retrieved from questionnaires and medical records. The patient health questionnaire 9 (PHQ-9) was used as an algorithm for a probable diagnosis of major depression employing a cut-off point 10. Logistic regression analyses were performed to identify risk factors for depression. RESULTS: Among these patients, 163 (46.8%) had no or minimal depression (PHQ-9 score 0-4), 108 (31.0%) had mild depression (PHQ-9 score 5-9) and 77 (22.1%) were at risk of major depression (PHQ-9 score >= 10). Patients with CD had a higher risk of major depression than those with UC (25.4% vs 15.8%, P = 0.040). PHQ-9 scores correlated strongly with clinical disease activity and quality of life scores in both groups but only weakly and solely in the CD group with biochemical disease activity. Clinical disease activity was identified as the only independent risk factor for depression in CD (odds ratio 7.814, 95% CI 2.688-22.717, P < 0.001), while no independent risk factor for depression was detected in UC. CONCLUSION: Achieving clinical remission in patients with IBD seems to be the most important factor to reduce the risk of depression.
引用
收藏
页码:456 / 467
页数:12
相关论文
共 30 条
[1]   Systematic review: psychological morbidity in young people with inflammatory bowel disease - risk factors and impacts [J].
Brooks, A. J. ;
Rowse, G. ;
Ryder, A. ;
Peach, E. J. ;
Corfe, B. M. ;
Lobo, A. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (01) :3-15
[2]   The burden of inflammatory bowel disease in Europe [J].
Burisch, Johan ;
Jess, Tine ;
Martinato, Matteo ;
Lakatos, Peter L. .
JOURNAL OF CROHNS & COLITIS, 2013, 7 (04) :322-337
[3]   Depression and inflammatory bowel disease: Finding from two nationally representative Canadian surveys [J].
Fuller-Thomson, Esme ;
Sulman, Joanne .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (08) :697-707
[4]   Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease [J].
Gauss, Annika ;
Geib, Thomas ;
Hinz, Ulf ;
Schaefert, Rainer ;
Zwickel, Philipp ;
Zawierucha, Anna ;
Stremmel, Wolfgang ;
Klute, Lukas .
MEDICINE, 2016, 95 (16)
[5]   Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study [J].
Goodhand, J. R. ;
Greig, F. I. S. ;
Koodun, Y. ;
McDermott, A. ;
Wahed, M. ;
Langmead, L. ;
Rampton, D. S. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (07) :1232-1239
[6]   Depression and Anxiety in Inflammatory Bowel Disease: A Review of Comorbidity and Management [J].
Graff, Lesley A. ;
Walker, John R. ;
Bernstein, Charles N. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (07) :1105-1118
[7]   Anxiety and Depression in Patients with Inflammatory Bowel Disease: Comparisons with Chronic Liver Disease Patients and the General Population [J].
Haeuser, Winfried ;
Janke, Karl-Heinz ;
Klump, Bodo ;
Hinz, Andreas .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (02) :621-632
[8]  
HARVEY RF, 1980, LANCET, V1, P514
[9]   Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis [J].
Higgins, PDR ;
Schwartz, M ;
Mapili, J ;
Krokos, I ;
Leung, J ;
Zimmermann, EM .
GUT, 2005, 54 (06) :782-788
[10]   Treatment with Immunosuppressive Therapy May Improve Depressive Symptoms in Patients with Inflammatory Bowel Disease [J].
Horst, Sara ;
Chao, Andrew ;
Rosen, Michael ;
Nohl, Anne ;
Duley, Caroline ;
Wagnon, Julianne H. ;
Beaulieu, Dawn B. ;
Taylor, Warren ;
Gaines, Lawrence ;
Schwartz, David A. .
DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) :465-470